The first quarter of 2026 continued to showcase REX's operational excellence and strategic discipline. Our team has once ...
As competitor search engines surge on Google's AI obsession, Microsoft has a very, very rare opportunity to exploit the ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Multiple milestones achieved or on track across wholly owned and partnered programs REC-1245 (RBM39 degrader): Early clinical data in solid ...
SALT LAKE CITY(AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $117.5 million in its first quarter. The Salt Lake City-based company said it had a ...
Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...
Josh D'Amaro took over Disney from Bob Iger in March after Iger's second retirement from the company. Today, he'll be looking back on the company's second quarter earnings for Fiscal Year 2026 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results